During the past decade, Eugene Marais Hospital; Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eugene Marais Hospital; Oncology" are "Esophageal Squamous Cell Carcinoma" (1 trials), "Non-Small-Cell Lung" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Eugene Marais Hospital; Oncology" in a lesser frequency.

Most popular intervention types in "Eugene Marais Hospital; Oncology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Atezolizumab Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eugene Marais Hospital; Oncology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Eugene Marais Hospital; Oncology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Eugene Marais Hospital; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eugene Marais Hospital; Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".